Valuation — not yet established
No valuation for North Texas Renal Management is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($16.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 6 rounds
- ·Watchlist + deal alerts for North Texas Renal Management
Create free account
No card required
Funding history
6 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Seed Round | $564K | ▮ | ▮ |
| Dec 2023 | Seed Round | $1.2M | ▮ | ▮ |
| Dec 2022 | Seed Round | $738K | ▮ | ▮ |
| Dec 2021 | Seed Round | $808K | ▮ | ▮ |
| Dec 2020 | Seed Round | $3.0M | ▮ | ▮ |
| Mar 2014 | Seed Round | $2.8M | ▮ | ▮ |
How North Texas Renal Management's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For North Texas Renal Management, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has North Texas Renal Management raised?
- North Texas Renal Management has raised $16.0M in total funding across 6 recorded rounds.
- When did North Texas Renal Management last raise?
- North Texas Renal Management last raised in Dec 2025 (Seed Round), raising $564K.